Add Yahoo as a preferred source to see more of our stories on Google. Prior to 1990, many assumed that once cholesterol plaques form in the arteries causing atherosclerosis, it was not reversible.
Liver transplant recipients show a higher prevalence of coronary atherosclerosis and high-risk plaque features compared with ...
The progression of atherosclerosis, at a cellular level, is reminiscent of the processes involved in tumor growth, new research confirms. Importantly, the idea itself is not new—but until now, the ...
Among patients with AD, GLP-1 RAs reduced the risk for various MACE outcomes, including heart failure, cerebrovascular disease, and more.
Amgen (NASDAQ:AMGN) announced today that Repatha® (evolocumab), when added to statins or other low-density lipoprotein cholesterol (LDL-C)-lowering treatments, reduced the risk of first major adverse ...
Research scientists at Aarhus University and Aarhus University Hospital have investigated the mechanisms by which hypertension leads to arterial damage and atherosclerosis. The results may facilitate ...
A new study has found that moderate increases in blood pressure and cholesterol have a greater impact on arterial plaque, or atherosclerosis, progression in 40-year-olds than in people over 48. The ...
In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results